Cargando…
COVID-19 infection manifesting as a severe gastroparesis flare: A case report
RATIONALE: Coronavirus disease 2019 (COVID-19) is a disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which commonly presents with symptoms including fever, cough, and dyspnea. More recently, however, some patients have tested positive for COVID-19 after...
Autores principales: | Song, Jun, Bhuta, Rajiv, Baig, Kamal, Parkman, Henry P., Malik, Zubair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036087/ https://www.ncbi.nlm.nih.gov/pubmed/33832159 http://dx.doi.org/10.1097/MD.0000000000025467 |
Ejemplares similares
-
Gastrointestinal symptoms in patients hospitalized with COVID-19: Prevalence and outcomes
por: Song, Jun, et al.
Publicado: (2022) -
Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report
por: Alhalabi, Marouf, et al.
Publicado: (2021) -
Severe Gastroparesis Flare: Is COVID-19 the Inciting Factor?
por: Patel, Aditya, et al.
Publicado: (2022) -
Short-term outcomes of different modalities of pyloromyotomy versus gastric electrical stimulation in the treatment of gastroparesis: A systemic review and meta-analysis
por: Shiu, Sz-Iuan, et al.
Publicado: (2021) -
Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)